BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 9044025)

  • 21. Antibacterial activity of T-5575, a novel 2-carboxypenam, and its stability to beta-lactamase.
    Matsumura N; Minami S; Mitsuhashi S
    J Antimicrob Chemother; 1997 Jan; 39(1):31-4. PubMed ID: 9044025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defining an extended-spectrum beta-lactamase.
    Livermore DM
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():3-10. PubMed ID: 18154524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains.
    Rossolini GM; Mantengoli E; Docquier JD; Musmanno RA; Coratza G
    New Microbiol; 2007 Jul; 30(3):332-9. PubMed ID: 17802921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods.
    Livermore DM
    Eur J Clin Microbiol; 1987 Aug; 6(4):439-45. PubMed ID: 3311738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of beta-lactamases in the resistance of gram-negative bacilli to beta-lactam antibiotics.
    Acar JF; Minozzi C
    Rev Infect Dis; 1986; 8 Suppl 5():S482-6. PubMed ID: 3541133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of chromosomal beta-lactamases to beta-lactam resistance in enterobacteria.
    Lindberg F; Normark S
    Rev Infect Dis; 1986; 8 Suppl 3():S292-304. PubMed ID: 3529322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of beta-lactamase induction.
    Phillips I; Shannon K
    Eur J Clin Microbiol Infect Dis; 1993; 12 Suppl 1():S19-26. PubMed ID: 8477758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Version 2000: the new beta-lactamases of Gram-negative bacteria at the dawn of the new millennium.
    Thomson KS; Smith Moland E
    Microbes Infect; 2000 Aug; 2(10):1225-35. PubMed ID: 11008112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular evolution of ubiquitous beta-lactamases towards extended-spectrum enzymes active against newer beta-lactam antibiotics.
    Collatz E; Labia R; Gutmann L
    Mol Microbiol; 1990 Oct; 4(10):1615-20. PubMed ID: 2077352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An overview of the response of bacteria to beta-lactam antibiotics.
    Greenwood D
    Rev Infect Dis; 1986; 8 Suppl 5():S487-95. PubMed ID: 3541134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Past and Present Perspectives on β-Lactamases.
    Bush K
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Updated functional classification of beta-lactamases.
    Bush K; Jacoby GA
    Antimicrob Agents Chemother; 2010 Mar; 54(3):969-76. PubMed ID: 19995920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of resistance to beta-lactam antibiotics.
    Livermore DM
    Scand J Infect Dis Suppl; 1991; 78():7-16. PubMed ID: 1947825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inoculum effect of β-lactam antibiotics.
    Lenhard JR; Bulman ZP
    J Antimicrob Chemother; 2019 Oct; 74(10):2825-2843. PubMed ID: 31170287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global dissemination of beta-lactamases mediating resistance to cephalosporins and carbapenems.
    Gootz TD
    Expert Rev Anti Infect Ther; 2004 Apr; 2(2):317-27. PubMed ID: 15482196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of beta-lactamase in Gram-negative bacteria.
    Wiedemann B; Peter K
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):131S-137S. PubMed ID: 2686915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Problems and changing patterns of resistance with gram-negative bacteria.
    Acar JF
    Rev Infect Dis; 1985; 7 Suppl 4():S545-51. PubMed ID: 3909311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful interventions for gram-negative resistance to extended-spectrum beta-lactam antiobiotics.
    Rice LB
    Pharmacotherapy; 1999 Aug; 19(8 Pt 2):120S-128S; discussion 133S-137S. PubMed ID: 10456609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical strategies for serious infection: a North American perspective.
    Quinn JP
    Diagn Microbiol Infect Dis; 1998 Jun; 31(2):389-95. PubMed ID: 9635914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. beta-Lactamase inhibitors.
    Cartwright SJ; Waley SG
    Med Res Rev; 1983; 3(4):341-82. PubMed ID: 6358721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.